Phase III Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer
18 Years
N/A
Both
Head and Neck Cancer
Trial Information
Phase III Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer
The purpose of this trial is to study the clinical effects of increasing the weekly fraction
number for locally advanced head and neck cancers by a multi-institutional prospective
randomised trial. The primary endpoint is to clarify whether a six fraction per week
protocol has a greater effect on the survival, as compared to the conventional five fraction
per week protocol.
Inclusion Criteria:
- Head and Neck Cancer
Exclusion Criteria:
- Unable to give an informed consent
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Three Years Loco-regional Control
Outcome Time Frame:
3 years
Safety Issue:
No
Principal Investigator
Eduardo Rosenblatt, M.D.
Investigator Role:
Study Director
Investigator Affiliation:
International Atomic Energy Agency (IAEA)
Authority:
United Nations: International Atomic Energy Agency
Study ID:
E33018
NCT ID:
NCT00120211
Start Date:
September 1998
Completion Date:
May 2006
Related Keywords:
- Head and Neck Cancer
- Head and Neck Neoplasms
Name | Location |
|---|
